Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps ...

Abnormal cells can clog blood vessels, leading to severe pain episodes and restricting oxygen delivery to vital organs ...

Read about the opening of London's newest blood donation centre, aiming to increase the number of Black heritage donors.

WINSTON-SALEM, N.C. — Emory Moore, a 12-year-old treated at Brenner Children’s Hospital for sickle cell disease, received a ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

People with sickle cell disease often struggle with memory, focus, learning and problem solving, setting them back in ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, ...

Texas Children's Hospital and Baylor College of Medicine are providing medication and other aid to fight sickle cell disease ...

Individuals with sickle cell disease—a chronic illness where misshapen, sticky blood cells clump together, reducing oxygen ...